Hardin Dean Mitchell Net Worth

The estimated Net Worth of Hardin Dean Mitchell is at least $2.17 Million dollars as of 9 February 2024. Mr Mitchell owns over 14,147 units of Enact Inc stock worth over $1,366,065 and over the last 3 years he sold ACT stock worth over $0. In addition, he makes $801,206 as EVP and CFO & Treasurer at Enact Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Mitchell ACT stock SEC Form 4 insiders trading

Mr has made over 3 trades of the Enact Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 14,147 units of ACT stock worth $496,984 on 9 February 2024.

The largest trade he's ever made was buying 20,000 units of Enact Inc stock on 20 September 2021 worth over $380,000. On average, Mr trades about 2,286 units every 48 days since 2021. As of 9 February 2024 he still owns at least 38,886 units of Enact Inc stock.

You can see the complete history of Mr Mitchell stock trades at the bottom of the page.

Mr. Hardin Dean Mitchell biography

Hardin Dean Mitchell is the EVP, CFO & Treasurer at Enact Inc.

What is the salary of Mr Mitchell?

As the EVP and CFO & Treasurer of Enact Inc, the total compensation of Mr Mitchell at Enact Inc is $801,206. There are 1 executives at Enact Inc getting paid more, with Rohit Gupta having the highest compensation of $3,175,003.

How old is Mr Mitchell?

Mr Mitchell is 51, he's been the EVP and CFO & Treasurer of Enact Inc since . There are 1 older and 4 younger executives at Enact Inc. The oldest executive at Enact Holdings Inc is Evan Scott Stolove, 52, who is the Exec. VP, Gen. Counsel & Sec..

What's Mr Mitchell's mailing address?

Hardin's mailing address filed with the SEC is C/O ENACT HOLDINGS, INC., 8325 SIX FORKS ROAD, RALEIGH, NC, 27615.

Insiders trading at Enact Inc

Over the last 12 years, insiders at Enact Inc have traded over $742,398,702 worth of Enact Inc stock and bought 189,956 units worth $3,738,670 . The most active insiders traders include Holdings, Inc. Genworth, Daniel J Iv Sheehan, and Michael A Bless. On average, Enact Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,061,714. The most recent stock trade was executed by Holdings, Inc. Genworth on 30 August 2024, trading 697,093 units of ACT stock currently worth $23,401,412.

What does Enact Inc do?

Enact Holdings, Inc. operates as a holding company. Through its subsidiaries, Enact provides mortgage insurance services to mortgage lenders and investors.

Complete history of Mr Mitchell stock trades at Enact Inc

Enact Inc executives and stock owners

Enact Inc executives and other stock owners filed with the SEC include:

• Rohit Gupta,
  Pres, CEO & Director
• Hardin Dean Mitchell,
  EVP, CFO & Treasurer
• Evan Scott Stolove,
  Exec. VP, Gen. Counsel & Sec.
• Piotr Bielinski,
  Chairman of the Management Board
• Slawomir Harazin,
  Vice Chairman of the Management Board
• Iwona Bocianowska,
  Chairwoman of the Supervisory Board
• Krzysztof Kaczmarczyk,
  Member of the Supervisory Board
• Piotr Chajderowski,
  Independent Member of the Supervisory Board
• Marek Jakubowski,
  Secretary of the Supervisory Board
• Adam Switalski,
  Independent Vice Chairman of the Supervisory Board
• Anna Bielinska,
  Director of Public Relations and Investor Relations
• Andrzej Bialy,
  Finance Director
• James Robert McMullen,
  Controller
• Michael Paul Derstine,
  Exec. VP & Chief Risk Officer
• Brian Michael Gould,
  EVP & COO
• Rohit Gupta,
  President and CEO
• Brian Gould,
  EVP & Chief Operations Officer
• James Mc Mullen,
  Controller
• Hardin Dean Mitchell,
  EVP, CFO and Treasurer
• Evan Stolove,
  EVP, Gen. Counsel & Secretary
• Michael Derstine,
  EVP and Chief Risk Officer
• Fred G Weiss,
  Director
• Ronald R Taylor,
  Director
• Jack Michelson,
  Director
• Cathy Klema,
  Director
• Andrew L Turner,
  Director
• Albert F Hummel,
  Director
• Michael J Fedida,
  Director
• George Fred Wilkinson,
  Pres-Global Brands&Biosimilars
• Michel J Feldman,
  Director
• R Todd Joyce,
  CFO-Global & PAO
• Sigurdur O Olafsson,
  Pres-Global Generics
• Chris W Bodine,
  Director
• Robert A Stewart,
  Pres-Global Operations
• Albert Iii Paonessa,
  President of Anda, Inc.
• Charles M Mayr,
  Chief Communic Off-Global
• Charles D Ebert,
  Sr. VP, Research & Development
• David A Buchen,
  Chief Legal Officer-Global&Sec
• Hafrun Fridriksdottir,
  Sr VP,Global Generics R&D
• Patrick Eagan,
  Chief HR Officer - Global
• Paul Bisaro,
  President & CEO
• Dominic James Addesso,
  Director
• Robert P Jr Restrepo,
  Director
• John D Fisk,
  Director
• Anne G Waleski,
  Director
• Westley V Thompson,
  Director
• Daniel J Iv Sheehan,
  Director
• Debra Still,
  Director
• Holdings, Inc. Genworth,
  
• Michael A Bless,
  Director
• Raymond T Odierno,
  Director
• Sheila Hooda,
  Director